Form DRSLTR - Correspondence Related to Draft Registration Statement:
SEC Accession No. 0000950123-23-006552
Filing Date
2023-08-01
Accepted
2023-08-01 17:05:20
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.htm DRSLTR 20474
2 GRAPHIC g523094g0728080408615.jpg GRAPHIC 2731
  Complete submission text file 0000950123-23-006552.txt   25447
Mailing Address 10 EARLSFORT TERRACE DUBLIN 2 L2 D02 T380
Business Address 10 EARLSFORT TERRACE DUBLIN 2 L2 D02 T380 353 1 905 8020
Mural Oncology Ltd (Filer) CIK: 0001971543 (see all company filings)

EIN.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: DRSLTR
SIC: 2834 Pharmaceutical Preparations